Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
Poumeaud, F., Morisseau, M., Cabel, L., Gonçalves, A., Rivier, C., Trédan, O., Volant, E., Frenel, J.-S., Ladoire, S., Jacot, W., Jamelot, M., Foka Tichoue, H., Patsouris, A., Teixeira, L., Bidard, F.-C., Loirat, D., Brunet, M., Levy, C., Bailleux, C., Cabarrou, B., Deleuze, A., Uwer, L., Deluche, E., Grellety, T., Franchet, C., Fiteni, F., Bischoff, H., Vion, R., Pagliuca, M., Verret, B., Bécourt, S., Reverdy, T., de Nonneville, A., Dalenc, F.
Published in British journal of cancer (07.09.2024)
Published in British journal of cancer (07.09.2024)
Get full text
Journal Article
1761P Clinical description and development of a prognosis score for neurofibromatosis type 1 (NF1) associated GISTs in the RECKGIST cohort: A retrospective study from the French NETSARC+ network
Cuvelier, C., Brahmi, M., Sobhani, I., Verret, B., Grancher, A., Penel, N., Toulmonde, M., Lahlou, W., Dupuis, H., Calavas, L., Muller, M., Watson, S., Bruyat, D., Poumeaud, F., Chaigneau, L., Manfredi, S., Lecomte, T., Bertucci, F., Bouche, O., Hautefeuille, V.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article